Luke Sergott
Stock Analyst at Barclays
(4.56)
# 1,019
Out of 4,698 analysts
758
Total ratings
49.2%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTRE Fortrea Holdings | Maintained: Hold | $22 | $18.62 | +18.15% | 22 | Sep 3, 2026 | |
| A Agilent Technologies | Maintained: Buy | $150 → $175 | $149.98 | +16.68% | 34 | Aug 27, 2026 | |
| BRKR Bruker | Maintained: Buy | $58 | $59.41 | -2.37% | 20 | Aug 25, 2026 | |
| NTRA Natera | Maintained: Buy | $260 → $340 | $327.67 | +3.76% | 15 | Aug 10, 2026 | |
| QGEN Qiagen | Maintained: Hold | $38 → $40 | $43.86 | -8.80% | 18 | Aug 7, 2026 | |
| SHC Sotera Health Company | Maintained: Buy | $19 → $22 | $19.03 | +15.61% | 43 | Aug 7, 2026 | |
| TXG 10x Genomics | Maintained: Buy | $40 → $52 | $63.22 | -17.75% | 35 | Aug 6, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $220 → $300 | $293.35 | +2.27% | 20 | Aug 5, 2026 | |
| PACB Pacific Biosciences of California | Maintained: Sell | $1.5 → $1.25 | $1.30 | -3.85% | 27 | Aug 5, 2026 | |
| WAT Waters | Maintained: Buy | $425 → $460 | $413.56 | +11.23% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.5 → $7.5 | $8.13 | -7.75% | 36 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 | $211.03 | +8.99% | 47 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 → $115 | $130.63 | -11.97% | 34 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,500 → $1,575 | $1,356.23 | +16.13% | 10 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $112 | $128.71 | -12.98% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $145 → $160 | $221.66 | -27.82% | 50 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $290 → $320 | $331.50 | -3.47% | 16 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $200 | $161.04 | +24.19% | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 → $275 | $271.62 | +1.24% | 49 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $13 | $15.19 | -14.42% | 45 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $175 | $169.61 | +3.18% | 12 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 → $250 | $239.40 | +4.43% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $625 → $650 | $618.43 | +5.10% | 46 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 | $342.73 | +16.71% | 11 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $450 | $593.39 | -24.16% | 10 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $150 → $175 | $163.58 | +6.98% | 41 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $42 | $6.91 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $266.28 | n/a | 1 | Jan 18, 2023 |
Fortrea Holdings
Sep 3, 2026
Maintained: Hold
Price Target: $22
Current: $18.62
Upside: +18.15%
Agilent Technologies
Aug 27, 2026
Maintained: Buy
Price Target: $150 → $175
Current: $149.98
Upside: +16.68%
Bruker
Aug 25, 2026
Maintained: Buy
Price Target: $58
Current: $59.41
Upside: -2.37%
Natera
Aug 10, 2026
Maintained: Buy
Price Target: $260 → $340
Current: $327.67
Upside: +3.76%
Qiagen
Aug 7, 2026
Maintained: Hold
Price Target: $38 → $40
Current: $43.86
Upside: -8.80%
Sotera Health Company
Aug 7, 2026
Maintained: Buy
Price Target: $19 → $22
Current: $19.03
Upside: +15.61%
10x Genomics
Aug 6, 2026
Maintained: Buy
Price Target: $40 → $52
Current: $63.22
Upside: -17.75%
Charles River Laboratories International
Aug 5, 2026
Maintained: Buy
Price Target: $220 → $300
Current: $293.35
Upside: +2.27%
Pacific Biosciences of California
Aug 5, 2026
Maintained: Sell
Price Target: $1.5 → $1.25
Current: $1.30
Upside: -3.85%
Waters
Aug 5, 2026
Maintained: Buy
Price Target: $425 → $460
Current: $413.56
Upside: +11.23%
Aug 5, 2026
Maintained: Hold
Price Target: $6.5 → $7.5
Current: $8.13
Upside: -7.75%
Aug 4, 2026
Maintained: Buy
Price Target: $230
Current: $211.03
Upside: +8.99%
Aug 4, 2026
Maintained: Hold
Price Target: $105 → $115
Current: $130.63
Upside: -11.97%
Aug 3, 2026
Maintained: Buy
Price Target: $1,500 → $1,575
Current: $1,356.23
Upside: +16.13%
Aug 3, 2026
Maintained: Buy
Price Target: $95 → $112
Current: $128.71
Upside: -12.98%
Jul 31, 2026
Maintained: Sell
Price Target: $145 → $160
Current: $221.66
Upside: -27.82%
Jul 31, 2026
Maintained: Hold
Price Target: $290 → $320
Current: $331.50
Upside: -3.47%
Jul 31, 2026
Maintained: Buy
Price Target: $150 → $200
Current: $161.04
Upside: +24.19%
Jul 29, 2026
Maintained: Buy
Price Target: $210 → $275
Current: $271.62
Upside: +1.24%
Jul 29, 2026
Maintained: Sell
Price Target: $8 → $13
Current: $15.19
Upside: -14.42%
Jul 28, 2026
Maintained: Buy
Price Target: $160 → $175
Current: $169.61
Upside: +3.18%
Jul 24, 2026
Maintained: Buy
Price Target: $230 → $250
Current: $239.40
Upside: +4.43%
Jul 24, 2026
Maintained: Buy
Price Target: $625 → $650
Current: $618.43
Upside: +5.10%
Jul 24, 2026
Maintained: Buy
Price Target: $400
Current: $342.73
Upside: +16.71%
Jul 23, 2026
Maintained: Hold
Price Target: $450
Current: $593.39
Upside: -24.16%
Jun 24, 2026
Maintained: Hold
Price Target: $150 → $175
Current: $163.58
Upside: +6.98%
Jun 12, 2023
Maintained: Hold
Price Target: $35 → $42
Current: $6.91
Upside: n/a
Jan 18, 2023
Rated: Buy
Price Target: $200
Current: $266.28
Upside: n/a